Camlin Fine Sciences has informed that subsequent to the approval accorded by the Board of Directors of the Company, at its meeting held on September 25, 2015 and the special resolution passed by the shareholders of the Company on December 02, 2015 by way of postal ballot for the QIP, the QIP Committee of the Company, on June 28, 2016 has, passed and authorised the opening of the QIP on June 28, 2016; Approving the preliminary placement document dated June 28, 2016 in connection with the QIP; and Approval of the floor price for the QIP. Further, the Relevant Date for this purpose, in terms of Regulation 81(c)(i) of the SEBI ICDR Regulations, is June 28, 2016 and accordingly the floor price in respect of the aforesaid QIP, based on the pricing formula as prescribed under Regulation 85(1) of the SEBI ICDR Regulations is Rs 89.89 per Equity Share. Pursuant to Regulation 85 of the SEBI ICDR Regulations the Company may offer a discount of not more than 5% on the floor price so calculated for the QIP.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3628.65 |
| Tata Chemicals | 801.15 |
| SRF | 2527.60 |
| Pidilite Inds. | 1363.45 |
| Deepak Nitrite | 1771.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: